Abiraterone

Overview

Abiraterone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL254328).

API suppliers (10)

Suppliers of Abiraterone evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• MSN Laboratories Private LimitedIndia3 active DMF GMP on record
• INDUSTRIALE CHIMICA SRLItaly2 active DMF GMP on record
• SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
• RAKS PHARMA PVT LTDIndia1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• Cipla USA, Inc.USA1 active DMF
• Shandong Anhong Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• Zhejiang Shenzhou Pharmaceutical Co., Ltd.China1 active DMF
• SCINOPHARM TAIWAN LTDTaiwan
• CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (22 approved US products), the latest listed US patent on Abiraterone expires 20 May 2034. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

Canonical SMILES

C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O

InChIKey

GZOSMCIZMLWJML-VJLLXTKPSA-N